Ben Slotman has served as Professor and Chairman of the Department of Radiation Oncology at Vrije Universiteit Medical Center (VUmc) in Amsterdam, The Netherlands since 1998. Since 2019, he is also chair of the department of Radiation Oncology at the AMC Amsterdam (which now together with VUmc forms the AmsterdamUMC).
Dr. Slotman received his MD in 1985 and PhD in 1990, both with highest honors at VU University in Amsterdam, The Netherlands and he was registered as radiation oncologist in 1994.
He is the (co)-author of more than 380 peer-reviewed publications. He has coordinated a number of trials, including the EORTC study on prophylactic cranial irradiation in extensive stage small cell lung cancer and the international randomized trial on the role of thoracic irradiation in these patients. His research activities are further concentrated on stereotactic radiotherapy and the introduction of various new technologies in radiotherapy, the latest being MRI-guided adaptive radiotherapy.
He was awarded Honorary Fellow of the American College of Radiology in 2017 and received the Jack I. Fabrikant award of the Int. Soc. For Radiosurgery (ISRS) in the same year. In 2018, he was awarded Fellow of ASTRO.
He served is currently Board member of the Radiosurgery Society (RSS), is past-president of the American Radium Society (ARS) and president-elect of ESTRO.